Alembic Pharma's Portfolio to Boom in 2019, an Industrial Info News Alert
Alembic Pharma's Portfolio to Boom in 2019, an Industrial Info News Alert
Attachment: India - pharma 0119
With the receipt of three back-to-back approvals from U.S. Food & Drug Administration (USFDA) in last two months, India's Alembic Pharmaceuticals is set to see a significant growth in its product portfolio in 2019
Subscribe Now!(All Fields Required)
Related Articles
Articles related to this company
- Samsung Biologics Constructing ADC Plant in South Korea
- Data Center Activity Propels Virginia to $12.7 Billion of Projects Under Co...
- Pharma Company Zoetis Signs PPA with Scout Clean Energy to Support Growing ...
- China's Rongsheng Petrochemical Ups Role in Polyester Chips
- Suffolk Construction Has Hand in $1.9 Billion Worth of Projects
Quick Links
- Home
- About Us
- Contact Us
- For Traders
Global Market Intelligence
- GMI Database Platform
- GMI Platform Tools
- Industry Coverage
- Analytics & Insights
- Advertising
